Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

Sunday. Post-lunch. The atmosphere was pure, low-grade tension. Write or stroll. That was the whole setup. The writing urge was bugging me; the whole day an ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of its previously announced ...